E-mail a copy of 'RXi Tackles RNAi Delivery, Pfizer Launches A Two-Cambridge Stem Cell Effort, Archemix Plows An Alternative Path to the Public Market, & More Boston-Area Life Sciences News' to a friend
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.